http://www.twitter.comTwitter is a service for friends, family, and co-workers to communicate and stay connected through the exchange of quick, frequent answers to one simple question: What are you doing?
View Older Stories View More Recent Stories
-
WeedMD Enters into Commercial Arrangement with Fire & Flower to produce CBD Cannabis Products
-
WeedMD Grants Deferred Share Units
-
WeedMD Signs Exclusive Licensing Agreement to Produce Mary’s Medicinals Premium Line of Wellness Products
-
WeedMD Announces Resignation of Dr. Hugh Scully from Board of Directors
-
WeedMD Appoints Canadian Entrepreneur Bruce Croxon to Board of Directors and Reports Results of AGM
-
WeedMD Partners with CannTx Life Sciences to Enhance Genetics Bank of New Cultivars and Preserve its Elite Proprietary Cannabis Strains
-
WeedMD Reports First Quarter 2020 Financial Results and Posts Record Revenue of $12.2 Million
-
WeedMD Cultivars Included in UHN-led Chronic Pain Study
-
WeedMD Announces Amendments to Existing Credit Facility
-
WeedMD Reaffirms Record Q1 2020 Preliminary Net Revenues of $12 Million and Confirms Earnings Call on July 15, 2020
-
WeedMD Launches Cannabis 2.0 Product Line of Medical Vaporizers
-
WeedMD Launches Same-Day Medical Cannabis Delivery Service
-
WeedMD Completes Planting Cannabis on its 27-Acre Outdoor Field and Provides Operational Update on CX Industries
-
WeedMD Reports Fiscal Year 2019 Financial Results and First Quarter 2020 Preliminary Revenue of $12 Million
-
WeedMD to File First Quarter 2020 Financials on or Before July 15
-
WeedMD Realigns Reporting Dates and Confirms Fiscal Year 2019 Financials to be Filed After Market on June 10, 2020
-
WeedMD to Present in Canaccord Genuity’s 4th Annual Global Cannabis Virtual Conference on May 12th at 8:40 a.m. ET
-
WeedMD to Report its Fiscal Year 2019 Financials on May 27, 2020
-
WeedMD Kicks-off Second Season of Outdoor Cannabis Cultivation
-
WeedMD Responds to UFCW Canada
-
WeedMD Announces Appointment of New Chief Financial Officer
-
WeedMD Posts Open Letter to Shareholders and Corporate Update from Newly-Appointed CEO
-
WeedMD Subsidiary Starseed Medicinal Signs the International Association of Heat and Frost Insulators and Allied Workers Local 95 to its Medical Cannabis Program
-
WeedMD Subsidiary Starseed Medicinal Signs the International Union of Painters and Allied Trades to Medical Cannabis Program
-
WeedMD Subsidiary Starseed Medicinal Secures Cannabis Research Licence from Health Canada
-
WeedMD Subsidiary Starseed Medicinal Signs Innovative Benefits Provider myHSA to Medical Cannabis Program
-
WeedMD Wins Award for London’s Best Places to Work 2020
-
WeedMD Wins Award for London’s Best Places to Work 2020
-
WeedMD Shareholders Approve the $25 Million Strategic Equity Investment, Subscription Receipts Exercise from LiUNA Pension Fund
-
WeedMD Shareholders Approve the $25 Million Strategic Equity Investment, Subscription Receipts Exercise from LiUNA Pension Fund
-
WeedMD Announces Leadership Change and Appoints New CEO as Company Accelerates Growth Initiatives
-
WeedMD Announces Leadership Change and Appoints New CEO as Company Accelerates Growth Initiatives
-
WeedMD to Hold Special Meeting of Shareholders on February 4th, 2020 at 10:00 a.m. to Finalize $25M Strategic Equity Investment
-
WeedMD Subsidiary Starseed Medicinal Signs LiUNA’s London, Ontario Local to Medical Cannabis Program
-
WeedMD Posts Open Letter to Shareholders
-
WeedMD Reports Third Quarter 2019 Financial Results and Announces Strategic Combination with Starseed
-
WeedMD Changes Third Quarter 2019 Earnings Conference Call Time to 1 p.m. EST on November 29th
-
WeedMD Appoints Seasoned Management Team to Lead Commercial Extraction Affiliate CX Industries Inc.
-
WeedMD to Host Third Quarter 2019 Earnings Conference Call on November 29 at 10 a.m. Eastern Time
-
WeedMD Provides Corporate Update and Schedules Q3 2019 Earnings Call for November 29th
-
WeedMD Secures Health Canada Licence for 50,000-Square-Foot Purpose-Built Cannabis Processing Facility
-
WeedMD to Host Media and VIP Open House to Showcase Harvest of its Outdoor-Cultivated Cannabis
-
WeedMD Reports Second Quarter 2019 Financial Results
-
WeedMD Assists in Completing Phase 1 of Shoppers Drug Mart & TruTrace's Medical Cannabis Verification Pilot
-
WeedMD Reports Preliminary Q2 Net Revenues of $8 Million and Confirms Earnings Call on August 29, 2019
-
WeedMD Secures Health Canada Approval for 20 Additional Cannabis Cultivation and Processing Rooms
-
CX Industries Signs Exclusive Agreement with Ignite International Brands to Supply Premium Cannabis and CBD Products
-
WeedMD Launches Cannabis Extraction Affiliate CX Industries
-
WeedMD Reports Results of Annual Meeting of Shareholders
-
WeedMD Established as First Licensed Producer in Shoppers Drug Mart’s Pilot Traceability Program for Medical Cannabis

